1Stafforini DM,Tjoelker LW,McCormick SP,et al.Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein[J],.J Biol Chem,1999,274(11):7018-7124.
2Sugano T,Nasu K,Narahara H,et al.Platelet-activating factor induces an imbalance between matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 expression in human uterine cervical fibroblasts[J],.Biol Reprod,2000,62(3):540-546.
3Carden DL,Granger DN.Pathophysiology of ischaemia-reperfusion injury[J],.J Pathol,2000,190(3):255-266.
4Oshiro T,Kakuta Y,Shimura S,et al.Characterization of platelet-activating factor-induced cytosolic calcium mobilization in human eosinophils[J],.Clin Exp Allergy,2000,30(5):699-705.
5Aihara M,Ishii S,Kume K,et al.Interaction between neurone and microglia mediated by platelet-activating factor[J],.Genes Cells,2000,5(5):397-406.
6Shenkar R,Abraham E.Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia:roles of reactive oxygen intermediates NF-kappa B and cyclic AMP response element binding protein[J],.J Immunol,1999,163(2):954-962.
7Landis RC,Haskard DO.Pathogenesis of crystal-induced inflammation[J],.Curr Rheumatol Rep,2001,3(1):36-41.
3Jayalakshmi K, Kumar S, Masa T, et al. Toll-like receptor signal transduction. Expland Mol Med, 2007, 39: 421-438.
4Sidiropoulos PI, Gouliehnos G, Voloudakis GK, et al. Inflammasomes and rheumatic diseases: evolving concepts. Ann Rheum Dis, 2008, 67: 1382-1389.
5Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature, 2003, 425: 516-521.
6Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of' the acute arthritis of primary gout. Arthritis Rheum, 1977, 20: 895-900.
7Kenneth J, Thomas D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 [-delta delta C(T)] method. Methods, 2001, 25: 402-408.
8Miao Z, Li C, Chen Y, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol, 2008, 35: 1859-1864.
9Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000--2005. Ann Rheum Dis, 2008, 67: 960-966.
10Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol, 2010, 11: 373-384.
